Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostaglandin E1 protects liver from ischemic damage

K Hanazaki1, T Kuroda, S Kajikawa

  • 1Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.

The Journal of Surgical Research
|September 1, 1994
PubMed
Summary

Prostaglandin E1 (PGE1) pretreatment protects the liver from metabolic damage caused by warm ischemia and reperfusion. This finding offers potential therapeutic strategies for liver preservation during surgical procedures.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gastrointestinal: Abdominal eggshell sign in a young woman with a pancreatic solid pseudopapillary neoplasm.

Journal of gastroenterology and hepatology·2022
Same author

Gastrointestinal: Giant gallbladder.

Journal of gastroenterology and hepatology·2022
Same author

Precise Measurement of Differential Cross Sections of the Σ^{-}p→Λn Reaction in Momentum Range 470-650  MeV/c.

Physical review letters·2022
Same author

Learning to stop: a unifying principle for legged locomotion in varying environments.

Royal Society open science·2021
Same author

An anthropomorphic soft skeleton hand exploiting conditional models for piano playing.

Science robotics·2020
Same author

Successful treatment of hyperkalaemia with insulin therapy using a closed-loop glycaemic control device.

Anaesthesia and intensive care·2016

Area of Science:

  • Hepatology
  • Surgical Research
  • Endocrinology

Background:

  • Normothermic liver ischemia can lead to significant metabolic derangements and organ damage.
  • Understanding the protective mechanisms against warm ischemia-reperfusion injury is crucial for improving patient outcomes.
  • Prostaglandin E1 (PGE1) is known for its vasodilatory and anti-inflammatory properties.

Purpose of the Study:

  • To investigate the efficacy of prostaglandin E1 (PGE1) pretreatment in mitigating hepatic metabolic disturbances during normothermic liver ischemia.
  • To evaluate the impact of PGE1 on insulin, glucagon, and glucose metabolism following liver ischemia-reperfusion.
  • To assess the effect of PGE1 on lipid peroxide production as an indicator of oxidative stress.

Main Methods:

  • A canine model was used, with dogs divided into control, ischemia-only, and PGE1-pretreated ischemia groups.

Related Experiment Videos

  • Liver ischemia was induced using the Pringle maneuver for 60 minutes.
  • PGE1 was administered intravenously at 0.5 microgram/kg/min for 30 minutes prior to ischemia induction.

    • Main Results:

    • The ischemia-only group exhibited decreased insulin and glucose metabolic clearance rates and increased lipid peroxide production.
    • In contrast, the PGE1-pretreated group showed improved hepatic insulin metabolism and normalized lipid peroxide levels.
    • Glucagon metabolism remained unaffected by ischemia in both experimental groups.

    Conclusions:

    • PGE1 pretreatment effectively prevents hepatic metabolic disturbances associated with warm ischemia and subsequent reperfusion.
    • PGE1 demonstrates a protective role against oxidative stress, indicated by reduced lipid peroxide production.
    • These findings suggest PGE1 as a potential therapeutic agent for liver protection during surgical interventions involving warm ischemia.